Maurizio Cammalleri Selected Research

Myelin-Oligodendrocyte Glycoprotein

3/2018

Fatty Acids Dietary Supplements Exert Anti-Inflammatory Action and Limit Ganglion Cell Degeneration in the Retina of the EAE Mouse Model of Multiple Sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maurizio Cammalleri Research Topics

Disease

17	Hypoxia (Hypoxemia) 01/2024 - 08/2007
14	Inflammation (Inflammations) 11/2023 - 01/2016
10	Diabetic Retinopathy (Retinopathy, Diabetic) 10/2023 - 07/2015
8	Glaucoma 11/2023 - 12/2019
7	Retinopathy of Prematurity (Retrolental Fibroplasia) 01/2024 - 01/2011
5	Retinal Diseases 01/2024 - 06/2015
5	Gliosis 01/2023 - 01/2017
5	Retinal Neovascularization 11/2021 - 08/2007
3	Ocular Hypertension (Glaucoma, Suspect) 11/2023 - 03/2020
2	Hemangioma (Angioma) 01/2024 - 01/2022
2	Hyperglycemia 11/2022 - 01/2017
2	Disease Progression 01/2022 - 01/2017
2	Neoplasms (Cancer) 01/2022 - 01/2019
2	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2020 - 01/2019
2	Ganglion Cysts (Ganglion) 03/2018 - 01/2017
2	Pathologic Neovascularization 01/2018 - 01/2016
2	Macular Degeneration (Age-Related Maculopathy) 09/2017 - 01/2016
2	Epilepsy (Aura) 04/2008 - 11/2004
1	Ischemia 07/2022
1	Geographic Atrophy 01/2022
1	Reperfusion Injury 12/2021
1	Neuralgia (Stump Neuralgia) 01/2021
1	Pain (Aches) 01/2021
1	Optic Nerve Diseases (Optic Neuropathy) 12/2020
1	Rare Diseases (Rare Disease) 01/2020
1	Oculocutaneous Albinism (Albinism, Yellow Mutant) 01/2020
1	Hermanski-Pudlak Syndrome (Hermansky-Pudlak Syndrome) 01/2020
1	Optic Nerve Injuries 12/2019
1	Melanoma (Melanoma, Malignant) 01/2019
1	Fibrosis (Cirrhosis) 01/2019
1	Eye Diseases (Eye Disease) 01/2019
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2019
1	Retinitis 01/2019
1	Vascular Diseases (Vascular Disease) 01/2019
1	Optic Neuritis (Retrobulbar Neuritis) 10/2018

Drug/Important Bio-Agent (IBA)

25	Retinaldehyde (Retinal)IBA 01/2023 - 08/2007
14	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2023 - 08/2007
10	Oxygen (Dioxygen)IBA 01/2024 - 01/2011
7	Propranolol (Inderal)FDA LinkGeneric 01/2024 - 01/2011
6	Octreotide (Sandostatin)FDA LinkGeneric 11/2022 - 11/2004
5	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2024 - 01/2019
4	AntioxidantsIBA 11/2023 - 01/2021
4	Methylcellulose (BFL)IBA 11/2023 - 03/2020
4	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2019 - 01/2016
3	Lisosan GIBA 10/2023 - 12/2018
3	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 11/2022 - 04/2008
3	Neuroprotective AgentsIBA 01/2021 - 01/2016
3	Fatty Acids (Saturated Fatty Acids)IBA 10/2018 - 09/2017
3	Transcription Factors (Transcription Factor)IBA 01/2017 - 02/2012
2	beta Adrenergic ReceptorsIBA 01/2023 - 01/2017
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2022 - 09/2017
2	Streptozocin (Streptozotocin)FDA Link 01/2021 - 01/2017
2	MelatoninIBA 12/2020 - 03/2020
2	agomelatine (S20098)IBA 12/2020 - 03/2020
2	tramiprosateIBA 04/2020 - 12/2019
2	ColforsinIBA 04/2020 - 12/2019
2	Vitamin B Complex (B Vitamins)IBA 04/2020 - 12/2019
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2011
2	Urokinase Plasminogen Activator ReceptorsIBA 01/2019 - 01/2017
2	Peptides (Polypeptides)IBA 01/2016 - 04/2008
2	somatostatin receptor 2IBA 02/2012 - 08/2007
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2024
1	Nerve Growth Factors (Neurotrophins)IBA 11/2023
1	PowdersIBA 10/2023
1	Hemoglobins (Hemoglobin)IBA 08/2023
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2023
1	Tight Junction ProteinsIBA 01/2023
1	Dihydrotachysterol (AT 10)IBA 01/2023
1	Niacin (Nicotinic Acid)FDA LinkGeneric 01/2023
1	Cytidine Diphosphate Choline (Citicoline)IBA 01/2023
1	XenobioticsIBA 01/2022
1	EstersIBA 01/2022
1	XanthophyllsIBA 01/2022
1	candesartan cilexetil (Amias)FDA Link 12/2021
1	angiotensin I (1-7)IBA 12/2021
1	Angiotensin IIIBA 12/2021
1	LuteinIBA 09/2021
1	Blood Glucose (Blood Sugar)IBA 01/2021
1	SecretagoguesIBA 01/2021
1	Gabapentin (Neurontin)FDA LinkGeneric 01/2021
1	Butyric Acid (Butanoic Acid)IBA 01/2021
1	Analgesics (Analgesic Drugs)IBA 01/2021
1	Ophthalmic Solutions (Eye Drops)IBA 12/2020
1	Brimonidine Tartrate (Alphagan)FDA LinkGeneric 12/2020
1	Adrenergic Agonists (Adrenergic Receptor Agonist)IBA 12/2020
1	Timolol (Blocadren)FDA LinkGeneric 12/2020
1	Conditioned Culture MediaIBA 11/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	DysbindinIBA 01/2020
1	oxalylglycineIBA 01/2020
1	VitaminsIBA 12/2019
1	Liver ExtractsIBA 01/2019
1	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 01/2019
1	Fibrinolysin FDA Link 01/2019
1	IntegrinsIBA 01/2019
1	PlasminogenIBA 01/2019

Therapy/Procedure

4	Therapeutics 01/2021 - 02/2012
2	Intracameral Injection 11/2023 - 01/2023
1	Nutritional Support (Artificial Feeding) 11/2023
1	Punctures 11/2020